To further investigate whether cGAMP targets the STING in the cGAS-cGAMP-STING-IRF3 pathway to facilitate antitumor activity, we examined the expression of STING and IRF3 in tumor tissues treated with cGAMP by immunofluorescence assay. Here, STING1 is linked to neoplasm.